While our study provides valuable insights into the role of CXCR1/2 signaling in metabolic diseases, ongoing research is essential to address remaining questions and potential safety concerns associated with therapeutic interventions targeting these receptors. The gene discussed is CXCR1; the disease is metabolic disease.